State-of-the-Art in Neuropathology
A special issue of Journal of Molecular Pathology (ISSN 2673-5261).
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 1946
Special Issue Editors
Interests: periodontitis; microbiology; neurodegeneration
Interests: neuropsychology; neurodegeneration; self-rated disability; clinical assessment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neuropathology is a discipline that nowadays encompasses many fields of medicine as the primary effect of neurological diseases or as the secondary effect of a systemic involvement from other conditions. Neuroinflammation in general as part of a chronic inflammatory state leads to a progressive cognitive decline and dementia or to different neural dysfunctions. The actual knowledge and the availability of lab and clinical advanced investigations have shed some light regarding the cellular involvement and its components, as mitochondria, the cytoskeleton and the membrane; however, further research is needed to combine the ultrastructural damage with the clinical signs and symptoms.
This Special Issue of the Journal of Molecular Pathology focuses on the recent advances in neurodegeneration to provide new evidence regarding the correlation between molecular and structural cell damage and the clinical semeiology with a particular focus on neuroinflammatory diseases leading to cognitive impairment and dementia.
You are welcome to submit new research papers and reviews to this Special Issue. Other acceptable manuscript types include methodological papers, position papers, brief reports, and commentaries.
We look forward to receiving your contributions.
Dr. Flavio Pisani
Dr. Valerio Pisani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Molecular Pathology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuropathology
- neuroinflammation
- cognitive impairment
- dementia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.